预测鼻内素治疗结果:一种机器学习,在治疗耐药抑郁症 (ESK-LEARNING) 中进行了为期三个月的研究
Mauro Pettorruso1, Roberto Guidotti1, Giacomo d'Andrea1
1Department of Neurosciences, Imaging and Clinical Sciences, Università degli Studi G. D'Annunzio, Chieti, Italy.
Psychiatry research
|August 13, 2023
概括
机器学习模型可以使用Esketamine鼻喷雾 (ESK-NS) 预测治疗耐药抑郁症 (TRD) 患者的治疗反应. 关键预测因素包括严重的无情和焦虑,而二胺使用可能会延迟反应.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 计算生物学 计算生物学
背景情况:
- 耐治疗抑郁症 (TRD) 带来了重大挑战,需要个性化治疗策略.
- 石胺鼻喷雾剂 (ESK-NS) 提供了一个新的治疗选择,但患者反应的预测因素在很大程度上是未知的.
- 预测工具对于优化ESK-NS在TRD管理中的有效性至关重要.
研究的目的:
- 确定TRD患者对ESK-NS反应的社会人口统计和临床预测因素.
- 开发和验证用于预测ESK-NS治疗结果的机器学习模型.
- 探索影响TRD反应和缓解率的因素.
主要方法:
- 一个回顾性,多中心,现实世界的研究,涉及149个TRD受试者.
- 在基线,1个月 (T1) 和3个月 (T2) 收集心理测量数据 (MADRS,BPRS,HAM-A,HAMD-17).
- 培训三个随机森林分类器来预测反应和缓解.
主要成果:
- 随机森林模型在T1实现了68.53%的预测准确度,在T2达到66.26%的响应,在T2达到68.60%的缓解.
- 严重的无情感,焦虑性焦虑,混合症状和双极性情绪正面预测了反应和缓解.
- bensodiazepine 使用和抑郁症严重程度与延迟治疗反应有关.
结论:
- 机器学习模型显示了预测TRD患者ESK-NS反应的潜力.
- 识别诸如无情和焦虑应急等预测因素可以指导个性化治疗策略.
- 需要进一步的研究,包括生物标志物,以提高预测准确性和临床实用性.
更多相关视频
05:19Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
2.3K
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.3K
相关概念视频
Electroconvulsive Therapy
69
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
69
Antidepressant Drugs: MAOIs and Other Agents
274
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
274
